Liwu Li Selected Research

Interleukin-1 Receptor-Associated Kinases

1/2017	Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle.
1/2017	A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection.
11/2013	Interleukin-1 receptor-associated kinase M (IRAK-M) promotes human rhinovirus infection in lung epithelial cells via the autophagic pathway.
11/2009	An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2.
4/2008	The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liwu Li Research Topics

Disease

29	Inflammation (Inflammations) 06/2022 - 04/2004
9	Endotoxemia 01/2021 - 12/2009
8	Infections 06/2022 - 04/2004
7	Neoplasms (Cancer) 01/2021 - 06/2006
7	Atherosclerosis 01/2019 - 12/2004
5	Sepsis (Septicemia) 01/2021 - 01/2003
5	Colitis 01/2019 - 04/2016
3	Body Weight (Weight, Body) 06/2022 - 09/2010
3	Chronic Disease (Chronic Diseases) 01/2021 - 01/2013
3	Bacterial Infections (Bacterial Infection) 01/2019 - 02/2012
3	Obesity 01/2017 - 05/2010
3	Prostatic Neoplasms (Prostate Cancer) 03/2006 - 04/2004
2	Pneumonia (Pneumonitis) 06/2022 - 01/2018
2	Asthma (Bronchial Asthma) 06/2022 - 01/2021
2	Carcinogenesis 01/2019 - 06/2006
2	Fatty Liver 04/2017 - 03/2016
2	Insulin Resistance 01/2017 - 05/2010
2	Type 2 Diabetes Mellitus (MODY) 05/2010 - 04/2003
1	Virus Diseases (Viral Diseases) 06/2022
1	Lung Injury 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Ulcerative Colitis 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Lupus Nephritis 11/2017
1	Atherosclerotic Plaque (Atheroma) 04/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Protein Deficiency 01/2017
1	Non-alcoholic Fatty Liver Disease 03/2016
1	Premature Birth (Birth, Premature) 04/2013
1	Persistent Infection 01/2013
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2012
1	Renal Insufficiency (Renal Failure) 01/2012

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2003
13	EndotoxinsIBA 01/2022 - 01/2003
9	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 04/2004
7	CytokinesIBA 06/2022 - 04/2003
7	LipopolysaccharidesIBA 01/2021 - 01/2003
5	Interleukin-1 Receptor-Associated KinasesIBA 01/2017 - 04/2008
3	Interleukin-33IBA 06/2022 - 01/2018
3	LipidsIBA 04/2017 - 12/2009
3	Apolipoproteins E (ApoE)IBA 04/2017 - 09/2008
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017 - 03/2006
3	Interleukin-10 (Interleukin 10)IBA 12/2016 - 12/2004
3	Biological ProductsIBA 11/2007 - 04/2004
2	InterferonsIBA 01/2022 - 11/2013
2	AntibodiesIBA 01/2021 - 06/2006
2	Interleukin-13IBA 01/2020 - 01/2018
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2020
2	Leukotriene B4IBA 01/2019 - 01/2019
2	CollagenIBA 02/2018 - 04/2017
2	ApolipoproteinsIBA 04/2017 - 03/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 05/2010
2	CholesterolIBA 01/2013 - 11/2009
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2011 - 01/2010
2	Toll-Like Receptor 4IBA 05/2010 - 04/2004
2	LigandsIBA 11/2009 - 01/2009
1	Adenosine Triphosphate (ATP)IBA 06/2022
1	ChemokinesIBA 06/2022
1	Apyrase (ATP Diphosphatase)IBA 06/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Cell Adhesion MoleculesIBA 01/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	ChitinIBA 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Dextrans (Dextran)FDA Link 01/2019
1	4-phenylbutylamineIBA 01/2019
1	Chemotactic FactorsIBA 01/2019
1	dectin 1IBA 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	methionyl-leucyl-phenylalanineIBA 01/2019
1	HydrogelsIBA 02/2018
1	Chemokine CCL24IBA 01/2018
1	Interleukin-22 (IL-22)IBA 01/2018
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	ursodoxicoltaurineIBA 10/2016
1	Fluorouracil (Carac)FDA LinkGeneric 04/2016
1	Thymidylate SynthaseIBA 04/2016
1	Transcription Factors (Transcription Factor)IBA 08/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2013
1	ArginaseIBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2012
1	Lipocalin-2IBA 01/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 04/2011
1	LeptinIBA 09/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
2	Punctures 01/2021 - 04/2015
2	Ligation 01/2021 - 04/2015
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Optical Fibers 01/2021
1	Immunotherapy 01/2020